跳至主要内容
临床试验/IRCT20201001048894N2
IRCT20201001048894N2招募中2 期

Evaluation of the effects of Annual SZ drug on modulating immune responses and efficacy against COVID-19 infection: a randomized clinical trial

Bandare-abbas University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 50 years(—)
性别
All

入选标准

  • Individuals with COVID-19 disease or control group according to specified grouping
  • Both genders from 20 to 50 years old
  • Definite infection with COVID-19 (people whose PCR is positive, HRCT is clear evidence of infection and have common symptoms of moderate disease of Covid-19
  • Signing an informed consent form

排除标准

  • Age less than 20 years and more than 50 years
  • People with cardiac arrhythmia, kidney, liver, metabolic or malignant diseases
  • Mental or skin diseases (rash, dermatitis, psoriasis)
  • Immunodeficiency diseases
  • Acute patient conditions and severe illness, the patient has shortness of breath, blood oxygen drop and the disease is worsening

研究者

发起方
Bandare-abbas University of Medical Sciences

相似试验